Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation

Archives of Neurology

Volumn 54, Issue 9, 1997, Pages 1166-1168

  Porzio, Salvatore ^a   Iorio, Raffade ^a   Vajro, Pietro ^a   Pensati, Pasqualina ^a   Vegnente, Angela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; ZINC;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DAILY LIFE ACTIVITY; HUMAN; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; TREMOR; WILSON DISEASE;

EID: 0030869711     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550210092019     Document Type: Article

References (12)

1. Iyengar V, Brewer GJ, Dick RD, Owyang C. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson disease. J Lab Clin Meet. 1988:111:267-274.
2. Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956:21:487-495.
3. Propst A, Propst T, Feichtinger H, Judmaier G, Willet J, Vogel W. Copper-induced acute rhabdomyolysis in Wilson disease. Gastroenterology. 1995;108; 885-887.
4. Adelman HM, Winters PR, Mahan CS, Wallach PM. D-Penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease. AmJ Med Sei. 1995:309:191-193.
5. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurological syndrome in patients with Wilson disease with initial penicillamine therapy. Arch Neurol. 1987:44:490-493.
6. Glass JD, Reich SG, DeLong MR. Wilson disease: development of neurological disease after beginning penicillamine therapy. Arch Neurol. 1990:47:595596.
7. Brewer GJ, Turkay A, Yuzbasiyan-Gurkan V. Development of neurologic symptoms in a patient with asymptomatic Wilson disease treated with penicillamine. Arch Neurol. 1994:51:304-305.
8. Sternlieb l, Scheinberg IH. Prevention of Wilson disease in asymptomatic patients. NEnglJMed. 1968:278:352-359.
9. Veen C, van den Hamer CJ, de Leeuw PW. Zinc sulphate therapy for Wilson disease after acute deterioration during treatment with low-dose o-penicillamine. J Intern Med. 1991 ;229:549-252.
10. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine. 1992:71:139-164.
11. McOuaid A, Lamand M, Mason J. The interaction of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implication for Wilson disease and arthritis therapy. J Lab Clin Med. 1992:119:744-750.
12. Starosta-Rubinstein S, Young AB, Kluin K, et al. Clinical assessment of 31 patients with Wilson disease: correlation with structural changes on magnetic resonance imaging. Arch Neurol. 1987:44:365-370.